# A Study of LY03003 in Patients With Early-stage Parkinson's Disease

> **NCT04044547** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Rotigotine, extended-release microspheres
- **DRUG:** Placebo, extended-release microspheres

## Key facts

- **NCT ID:** NCT04044547
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-22
- **Primary completion:** 2014-02-26
- **Final completion:** 2015-06-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044547, "A Study of LY03003 in Patients With Early-stage Parkinson's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04044547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*